Q4 2023 Immunocore Holdings PLC Earnings Call Transcript
Greetings welcome to the Immunocore fourth quarter financial results conference call. (Operator Instructions) Please note this conference is being recorded. I will now turn the conference over to Clayton Robertson, Head of Investor Relations. Thank you may begin.
Thank you, [Daryl]. Welcome, everyone, to our Q4 and full year 2023 financial results call. Before we begin, I would like to remind you that this call will contain forward-looking statements within the meaning of the Safe Harbor provision under the Private Securities Litigation Reform Act of 1995.
These include expectations, plans concerning future events, prospects, and performance including with respect to commercialization, clinical development and trials, regulatory approvals, and financial results. Actual events may differ materially from those indicated by these forward-looking statements as a result of various important factors, including those disclosed in our filings with the SEC.
And such statements
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |